7-Deoxyadriamycinol aglycone

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 591218

CAS#: 37818-13-6

Description: 7-Deoxyadriamycinol aglycone is an adriamycin metabolite.


Chemical Structure

img
7-Deoxyadriamycinol aglycone
CAS# 37818-13-6

Theoretical Analysis

MedKoo Cat#: 591218
Name: 7-Deoxyadriamycinol aglycone
CAS#: 37818-13-6
Chemical Formula: C21H20O8
Exact Mass: 400.1158
Molecular Weight: 400.38
Elemental Analysis: C, 63.00; H, 5.04; O, 31.97

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: 7-Deoxyadriamycinol aglycone;

IUPAC/Chemical Name: 5,12-Naphthacenedione, 8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (S-(R*,S*))-

InChi Key: IGJIPNOEJDYNRR-ASSNKEHSSA-N

InChi Code: InChI=1S/C21H20O8/c1-29-12-4-2-3-10-14(12)20(27)16-15(18(10)25)19(26)11-7-21(28,13(23)8-22)6-5-9(11)17(16)24/h2-4,13,22-24,26,28H,5-8H2,1H3/t13-,21+/m1/s1

SMILES Code: O=C(C1=C2C(O)=C3CC[C@@](O)([C@H](O)CO)CC3=C1O)C4=CC=CC(OC)=C4C2=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 400.38 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Gille L, Nohl H. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radic Biol Med. 1997;23(5):775-82. PubMed PMID: 9296455.

2: Samuel L. Doxorubicin-induced cardiotoxicity. Postgrad Med J. 1995 May;71(835):318. PubMed PMID: 7596949; PubMed Central PMCID: PMC2398096.

3: Cummings J, Milstead R, Cunningham D, Kaye S. Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: evidence from metabolites identified in serum. Eur J Cancer Clin Oncol. 1986 Aug;22(8):991-1001. PubMed PMID: 3770056.

4: Dodion P, Riggs CE Jr, Akman SR, Bachur NR. Effect of hyperthermia on the in vitro metabolism of doxorubicin. Cancer Treat Rep. 1986 May;70(5):625-9. PubMed PMID: 3708610.

5: Creagan ET, Ahmann DL, Frytak S, Long HJ, Chang MN, Itri LM. Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients. Cancer Treat Rep. 1986 May;70(5):619-24. PubMed PMID: 3518925.

6: Vrignaud P, Londos-Gagliardi D, Robert J. Hepatic metabolism of doxorubicin in mice and rats. Eur J Drug Metab Pharmacokinet. 1986 Apr-Jun;11(2):101-5. PubMed PMID: 3770010.

7: Cummings J, Merry S, Willmott N. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS). Eur J Cancer Clin Oncol. 1986 Apr;22(4):451-60. PubMed PMID: 3460809.

8: Dodion P, Riggs CE Jr, Akman SR, Tamburini JM, Colvin OM, Bachur NR. Interactions between cyclophosphamide and adriamycin metabolism in rats. J Pharmacol Exp Ther. 1984 Apr;229(1):51-7. PubMed PMID: 6423814.

9: Marshall VP, McGovren JP, Richard FA, Richard RE, Wiley PF. Microbial metabolism of anthracycline antibiotics daunomycin and adriamycin. J Antibiot (Tokyo). 1978 Apr;31(4):336-42. PubMed PMID: 26650.